SiteRx
PrivateLast Round
Series B
Nov 3, 2021
Total Funding Raised
$10M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
SiteRx operates in Healthcare & Life Sciences and is based in New York City, New York. Its latest recorded funding round was a Series B round in November 2021.
SiteRx is a healthcare technology company that provides a clinical trial management platform to connect patients and healthcare providers with research opportunities.
Sector
Healthcare & Life Sciences
Verticals
Clinical Trials, Patient Engagement, Medical AI, Vertical SaaS, Workflow Automation
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SiteRx Comparables
Compare SiteRx with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| TrialX | 82% | |
| Trialbee | 82% | |
| Reify Health | 79% |
For institutional investors. Book with your work email.
SiteRx Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Nov 3, 2021 | ||||
| Series A | Sep 1, 2020 | ||||
| Pre Seed | Jun 1, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
SiteRx Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| 01 Advisors | Series B |
| First Round Capital | Series B |
| Valor Equity Partners | Series B |
| CoFound Partners | Series B |
| Eugene M. Lang Entrepreneurial Initiative Fund | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 20, 2026
Open roles increased to 200, 120% of current headcount.
- May 19, 2026
Monthly visitors increased 46% MoM.
For institutional investors. Book with your work email.
SiteRx Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about SiteRx's valuation, stock price, and market status.
Is SiteRx a public or private company?
SiteRx is a private company.
What is the current stock price of SiteRx?
SiteRx is a private company, so its shares have no public market price. Caplight tracks SiteRx's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is SiteRx worth (valuation)?
Valuation information for SiteRx is not publicly available.
Can I buy SiteRx stock?
SiteRx shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was SiteRx's last funding round?
SiteRx's most recent funding round was Series B on November 3, 2021.
Who are the main investors in SiteRx?
Key investors in SiteRx include CoFound Partners.
Will SiteRx IPO soon?
No public IPO plans have been announced for SiteRx.
How can I track SiteRx secondary market activity?
Caplight tracks bids, offers, and trades in SiteRx's shares on secondary markets.